Shi H - Search Results

1

Diagnostic and prognostic value of scavenger receptor class B type 1 in clear cell renal cell carcinoma.

Xu G, Lou N, Xu Y, Shi H, Ruan H, Xiao W, Liu L, Xiao H, Qiu B, Bao L, Yuan C, Chen K, Yang H, Zhang X. Xu G, et al. Among authors: shi h. Tumour Biol. 2017 May;39(5):1010428317699110. doi: 10.1177/1010428317699110. Tumour Biol. 2017. PMID: 28466781 Free article.

2

miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.

Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu X, Xiao P, Shi H, Wang R, Chen L, Chen S, Du Q, Yang H, Zhang X. Chen X, et al. Among authors: shi h. Clin Cancer Res. 2014 May 15;20(10):2617-30. doi: 10.1158/1078-0432.CCR-13-3224. Epub 2014 Mar 19. Clin Cancer Res. 2014. PMID: 24647573

3

Discovery of urine biomarkers for bladder cancer via global metabolomics.

Shi H, Li X, Zhang Q, Yang H, Zhang X. Shi H, et al. Biomarkers. 2016 Nov;21(7):578-88. doi: 10.3109/1354750X.2016.1171903. Epub 2016 May 2. Biomarkers. 2016. PMID: 27133288 Review.

4

miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.

Lou N, Ruan AM, Qiu B, Bao L, Xu YC, Zhao Y, Sun RL, Zhang ST, Xu GH, Ruan HL, Yuan CF, Han WW, Shi HC, Yang HM, Zhang XP. Lou N, et al. Urol Oncol. 2017 Jan;35(1):36.e7-36.e14. doi: 10.1016/j.urolonc.2016.07.012. Epub 2016 Sep 12. Urol Oncol. 2017. PMID: 27633984

5

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.

Xu GH, Lou N, Shi HC, Xu YC, Ruan HL, Xiao W, Liu L, Li X, Xiao HB, Qiu B, Bao L, Yuan CF, Zhou YL, Hu WJ, Chen K, Yang HM, Zhang XP. Xu GH, et al. BMC Cancer. 2018 Jan 22;18(1):88. doi: 10.1186/s12885-017-3761-z. BMC Cancer. 2018. PMID: 29357836 Free PMC article.

6

Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis.

Shi H, Yu H, Bellmunt J, Leow JJ, Chen X, Guo C, Yang H, Zhang X. Shi H, et al. Qual Life Res. 2018 Nov;27(11):2759-2775. doi: 10.1007/s11136-018-1902-8. Epub 2018 Jun 20. Qual Life Res. 2018. PMID: 29926345

7

Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.

Shi H, Sun Y, He M, Yang X, Hamada M, Fukunaga T, Zhang X, Chang C. Shi H, et al. Oncogene. 2020 Jan;39(3):530-545. doi: 10.1038/s41388-019-0962-8. Epub 2019 Sep 9. Oncogene. 2020. PMID: 31501521 Free PMC article.

8

CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials.

Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X. Cao Q, et al. Among authors: shi h, shi d. J Cancer Res Ther. 2020 Sep;16(5):990-1001. doi: 10.4103/jcrt.JCRT_295_18. J Cancer Res Ther. 2020. PMID: 33004739 Free article.

9

Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling.

He M, Yang H, Shi H, Hu Y, Chang C, Liu S, Yeh S. He M, et al. Among authors: shi h. Cancer Lett. 2022 Jan 1;524:15-28. doi: 10.1016/j.canlet.2021.08.028. Epub 2021 Aug 27. Cancer Lett. 2022. PMID: 34461182

10

Properties and functions of KATP during mouse perinatal development.

Nie L, Tang M, Zeng Y, Jiang H, Shi H, Luo H, Hu X, Gao L, Xi J, Liu A, Reppel M, Hescheler J, Liang H. Nie L, et al. Among authors: shi h. Biochem Biophys Res Commun. 2012 Feb 3;418(1):74-80. doi: 10.1016/j.bbrc.2011.12.133. Epub 2012 Jan 9. Biochem Biophys Res Commun. 2012. PMID: 22252295

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,485 results

Search Page

Filters